Stem cell-derived ‘mini-brains’ reveal potential drug treatment for rare disorder

Their findings are published in the September 8 online issue of Molecular Psychiatry. The neurological disorder is called MECP2 duplication syndrome. First described in 2005, it is caused by duplication of genetic material in a specific region of the X …

[Read the full article here]

Comments are closed.